RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Stockholders' equity

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.3B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 2024588+52.15%
Dec 31, 2023387-32.50%
Dec 31, 2022573-25.77%
Dec 31, 2021772-8.49%
Dec 31, 2020843-49.94%
Dec 31, 20191,685+41.90%
Dec 31, 20181,187+183.52%
Dec 31, 2017419+320.55%
Dec 31, 2016100-50.41%
Dec 31, 2015201-22.11%
Dec 31, 2014258-31.87%
Dec 31, 2013378+107.04%
Dec 31, 2012183+6.61%
Dec 31, 2011171-29.90%
Dec 31, 2010245

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)